Drug Free Solution, Inc.
DSOL · OTC
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | – | – | – | -$1,407 |
| Dep. & Amort. | – | – | – | $12 |
| Deferred Tax | – | – | – | $0 |
| Stock-Based Comp. | – | – | – | $0 |
| Change in WC | – | – | – | $77 |
| Other Non-Cash | – | – | – | $935 |
| Operating Cash Flow | – | – | – | -$383 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | – | – | – | -$37 |
| Net Acquisitions | – | – | – | $0 |
| Inv. Purchases | – | – | – | $0 |
| Inv. Sales/Matur. | – | – | – | $0 |
| Other Inv. Act. | – | – | – | $0 |
| Investing Cash Flow | – | – | – | -$37 |
| Financing Activities | – | – | – | – |
| Debt Repay. | – | – | – | $0 |
| Stock Issued | – | – | – | $430 |
| Stock Repurch. | – | – | – | $0 |
| Dividends Paid | – | – | – | $0 |
| Other Fin. Act. | – | – | – | $0 |
| Financing Cash Flow | – | – | – | $430 |
| Forex Effect | – | – | – | $0 |
| Net Chg. in Cash | – | – | – | $10 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | – | – | – | $3 |
| End Cash | – | – | – | $13 |
| Free Cash Flow | – | – | – | -$420 |